Cargando…

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

BACKGROUND: The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and suscep...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, N., Meacci, A., Mora, B., Vestri, A., Picarelli, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856018/
https://www.ncbi.nlm.nih.gov/pubmed/35175152
http://dx.doi.org/10.1080/07853890.2022.2039955
_version_ 1784653752011063296
author Greco, N.
Meacci, A.
Mora, B.
Vestri, A.
Picarelli, A.
author_facet Greco, N.
Meacci, A.
Mora, B.
Vestri, A.
Picarelli, A.
author_sort Greco, N.
collection PubMed
description BACKGROUND: The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and susceptibility to viruses, such as SARS-CoV. In our study, we examined a population of coeliac subjects presenting the HLA haplotype DQ2 and/or DQ8. Our aim was to evaluate whether HLA DQ2 and/or DQ8 haplotype play a role in SARS-CoV-2-infection. The aim was also to evaluate the difficulty in following the gluten-free diet due to all the adversities produced by the pandemic, such as the food supply disruption, and the difficulties in managing the clinical follow-up. METHODS: 191 consecutive coeliac patients completed a questionnaire on their current clinical status, psychological effects, and management of the gluten-free diet experienced during the COVID-19 pandemic and questions regarding possible SARS-CoV-2 infection. RESULTS: Out of the 191 patients who participated in the study, 42 were full-blown coeliac and 149 were in remission. From the answers provided, 84.8% of patients declared that they no longer consider themselves vulnerable to COVID-19 as they suffer from coeliac disease; 94.2% of patients did not encounter any difficulties in managing the gluten-free diet or in acquiring specific foods and 64.9% of patients in our study underwent diagnostic testing for SARS-CoV-2. Out of this number, 31.5% did so due to contacts with subjects affected by COVID-19, 26.6% for work related reasons, 11.3% due to flu-like symptoms and 30.6% for other reasons. Only 5.8% of the enrolled patients received a diagnosis of COVID-19. Out of all the patients in our population who were diagnosed with COVID-19, 94.8% developed no symptoms and none of them needed hospitalization or intensive care. CONCLUSION: The hypothesis that the HLADQ2 and/or DQ8 haplotype plays a protective role against SARS-CoV-2 infection, as against other viral infections, is intriguingly suggestive. KEY MESSAGES: COVID-19 as a public health emergency; SARS-CoV-2 and possible complications in coeliac disease; Role of HLA DQ2 and/or DQ8 in SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8856018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88560182022-02-19 Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect? Greco, N. Meacci, A. Mora, B. Vestri, A. Picarelli, A. Ann Med Gastroenterology & Hepatology BACKGROUND: The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and susceptibility to viruses, such as SARS-CoV. In our study, we examined a population of coeliac subjects presenting the HLA haplotype DQ2 and/or DQ8. Our aim was to evaluate whether HLA DQ2 and/or DQ8 haplotype play a role in SARS-CoV-2-infection. The aim was also to evaluate the difficulty in following the gluten-free diet due to all the adversities produced by the pandemic, such as the food supply disruption, and the difficulties in managing the clinical follow-up. METHODS: 191 consecutive coeliac patients completed a questionnaire on their current clinical status, psychological effects, and management of the gluten-free diet experienced during the COVID-19 pandemic and questions regarding possible SARS-CoV-2 infection. RESULTS: Out of the 191 patients who participated in the study, 42 were full-blown coeliac and 149 were in remission. From the answers provided, 84.8% of patients declared that they no longer consider themselves vulnerable to COVID-19 as they suffer from coeliac disease; 94.2% of patients did not encounter any difficulties in managing the gluten-free diet or in acquiring specific foods and 64.9% of patients in our study underwent diagnostic testing for SARS-CoV-2. Out of this number, 31.5% did so due to contacts with subjects affected by COVID-19, 26.6% for work related reasons, 11.3% due to flu-like symptoms and 30.6% for other reasons. Only 5.8% of the enrolled patients received a diagnosis of COVID-19. Out of all the patients in our population who were diagnosed with COVID-19, 94.8% developed no symptoms and none of them needed hospitalization or intensive care. CONCLUSION: The hypothesis that the HLADQ2 and/or DQ8 haplotype plays a protective role against SARS-CoV-2 infection, as against other viral infections, is intriguingly suggestive. KEY MESSAGES: COVID-19 as a public health emergency; SARS-CoV-2 and possible complications in coeliac disease; Role of HLA DQ2 and/or DQ8 in SARS-CoV-2 infection. Taylor & Francis 2022-02-17 /pmc/articles/PMC8856018/ /pubmed/35175152 http://dx.doi.org/10.1080/07853890.2022.2039955 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Gastroenterology & Hepatology
Greco, N.
Meacci, A.
Mora, B.
Vestri, A.
Picarelli, A.
Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title_full Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title_fullStr Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title_full_unstemmed Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title_short Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
title_sort coeliac disease in the covid-19 pandemic: does hla have a protective effect?
topic Gastroenterology & Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856018/
https://www.ncbi.nlm.nih.gov/pubmed/35175152
http://dx.doi.org/10.1080/07853890.2022.2039955
work_keys_str_mv AT grecon coeliacdiseaseinthecovid19pandemicdoeshlahaveaprotectiveeffect
AT meaccia coeliacdiseaseinthecovid19pandemicdoeshlahaveaprotectiveeffect
AT morab coeliacdiseaseinthecovid19pandemicdoeshlahaveaprotectiveeffect
AT vestria coeliacdiseaseinthecovid19pandemicdoeshlahaveaprotectiveeffect
AT picarellia coeliacdiseaseinthecovid19pandemicdoeshlahaveaprotectiveeffect